Cargando…
Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787024/ https://www.ncbi.nlm.nih.gov/pubmed/35075785 http://dx.doi.org/10.1002/ctm2.583 |
| _version_ | 1784639268458594304 |
|---|---|
| author | Cai, Jinhua Xue, Ruiqi Yue, Zongwei Zhang, Zhan He, Lei Li, Honghong Li, Yi Rong, Xiaoming Zhang, Xiaoni Xu, Yongteng Tang, Yamei |
| author_facet | Cai, Jinhua Xue, Ruiqi Yue, Zongwei Zhang, Zhan He, Lei Li, Honghong Li, Yi Rong, Xiaoming Zhang, Xiaoni Xu, Yongteng Tang, Yamei |
| author_sort | Cai, Jinhua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8787024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87870242022-01-31 Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients Cai, Jinhua Xue, Ruiqi Yue, Zongwei Zhang, Zhan He, Lei Li, Honghong Li, Yi Rong, Xiaoming Zhang, Xiaoni Xu, Yongteng Tang, Yamei Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-01-24 /pmc/articles/PMC8787024/ /pubmed/35075785 http://dx.doi.org/10.1002/ctm2.583 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Cai, Jinhua Xue, Ruiqi Yue, Zongwei Zhang, Zhan He, Lei Li, Honghong Li, Yi Rong, Xiaoming Zhang, Xiaoni Xu, Yongteng Tang, Yamei Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title | Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title_full | Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title_fullStr | Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title_full_unstemmed | Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title_short | Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| title_sort | neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787024/ https://www.ncbi.nlm.nih.gov/pubmed/35075785 http://dx.doi.org/10.1002/ctm2.583 |
| work_keys_str_mv | AT caijinhua neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT xueruiqi neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT yuezongwei neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT zhangzhan neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT helei neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT lihonghong neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT liyi neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT rongxiaoming neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT zhangxiaoni neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT xuyongteng neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients AT tangyamei neutrophiltolymphocyteratioasapredictorfortreatmentofradiationinducedbrainnecrosiswithbevacizumabinnasopharyngealcarcinomapatients |